MONTREAL, Aug. 3 /PRNewswire-FirstCall/ - AKELA Pharma Inc., (TSX: AKL - News), a drug development company focused on developing therapies for the inhalation, pain and CNS markets, today announced that it will report financial results for the second quarter of fiscal 2007 ended June 30, 2007 on Tuesday August 14, 2007.
